In Victaulic Company v. ASC Engineered Sols., LLC, the District of Delaware ruled on summary judgment that ASC is estopped from asserting two obviousness grounds against a patent claim because it raised the same grounds in inter partes reexamination proceedings. At issue was whether pre-America Invents Act (AIA) reexamination estoppel under 35 U.S.C. § 315(c) applies even if the patent owner raises a different claim construction in district court than the USPTO applied during reexamination. The District Court answered “yes,” reasoning that a “party’s proposed construction of a term does not change . . . whether a party previously asserted that a claim … was obvious in an inter partes reexamination.”
D. Del.: Plaintiff’s Seeking Broader Construction in District Court Rather Than in Reexamination Does Not Preclude Reexamination Estoppel
February 6, 2023
Reading Time : 1 min
Victaulic owns U.S. Patent No. 7,712,796 (“the ʼ796 Patent”), which relates to a “deformable mechanical pipe coupling.” Independent claims 1, 21, 41 and 44 of the ʼ796 Patent each includes a “being deformable” limitation, which recites “said segments being deformable upon adjustable tightening of said connection members so as to substantially conform the curvature of said arcuate surfaces to the outer surfaces of said pipe elements within said circumferential grooves.”
In 2012, ASC requested inter partes reexamination of certain claims of the ʼ796 Patent, including claims 1, 21, 41 and 44. ASC’s request asserted obviousness grounds against those claims based on “Reynolds” and “Reynolds in view of Webb.” The USPTO instituted reexamination on both of those grounds but determined that the claims were “valid and patentable” in a final decision.
Notably, during reexamination, the USPTO agreed to add language to the “being deformable” limitation in claims 21, 41 and 44—but not in claim 1. However, the USPTO “mistakenly omitted” the added language from its decision, and the claims were not formally amended to add that language.
In 2020, Victaulic asserted claim 1 of the ʼ796 Patent against ASC in the District of Delaware, among other claims. In its invalidity contentions for claim 1, ASC again asserted “Reynolds” and “Reynolds in view of Webb.”
In a motion for summary judgment, Victaulic argued that ASC was estopped from asserting “Reynolds” or “Reynolds in view of Webb” against claim 1 under 35 U.S.C. § 315(c) because ASC raised those grounds in the reexamination proceedings. Section 315(c) states that a “third-party requester” like ASC is “estopped from asserting at a later time, in any civil action . . . the invalidity of any claim finally determined to be valid and patentable on any ground which the [] requester raised or could have raised during the inter partes reexamination proceedings.”
In response, ASC argued that its Reynolds and Webb-based obviousness grounds were not “raised” and “could not have been raised” in the reexamination proceedings because the two proceedings involve different claim interpretations of the “being deformable” limitation in claim 1. Specifically, ASC argued that, during reexamination, the USPTO applied a narrow interpretation of “being deformable” in claim 1 that necessarily included the additional language that was supposed to be added to claims 21, 41 and 41. Thus, according to ASC, estoppel should not apply because “Victaulic now asserts an interpretation of the [‘being deformable’] claim limitation . . . in claim 1 that is broader than the Board’s interpretation of the claim,” which presents new “issues” when asserting Reynolds and Webb in district court.
The District Court rejected ASC’s argument, ruled that estoppel applied, and granted summary judgment in favor of Victaulic. In coming to its conclusion, the District Court determined that “raised or could have raised” in § 315(c) refers to whether the same claims are at issue, not the same interpretations, citing In re Affinity Labs of Texas, LLC, 856 F.3d 883, 891-92 (Fed. Cir. 2017). When ASC requested reexamination, claim 1 “had the same language as it has now,” which “has only ‘one correct construction.’” Accordingly, even if Victaulic is applying a different construction than the USPTO, that “does not change either how the Court must construe that term or whether a party previously asserted that a claim which includes that term was obvious in an inter partes reexamination.” Accordingly, ASC was “estopped from asserting in this action that Claim 1 of the ʼ796 Patent is invalid as obvious in view of Webb and Reynolds because ASC raised or could have raised those invalidity grounds in the [reexamination].”
The District Court further noted in a footnote that “ASC could have raised its real argument—i.e., that the IPR added limitations to Claim 1” had it not “forfeited the chance to bring such a motion” (citing a sealed document).
Practice Tip: In light of estoppel provisions under pre- and post-AIA patent statutes, practitioners should proceed with caution when asserting the same prior art in district court that they asserted in prior proceedings, including reexaminations, before the USPTO. As shown in Victaulic, the Patent Act’s estoppel provisions are “severe” and may apply even if claims are interpreted or construed differently between the proceedings.
Victaulic Company v. ASC Engineered Sols., LLC., Civil Action No. 20-887-GBW (D. Del. Nov. 30, 2022).
Victaulic owns U.S. Patent No. 7,712,796 (“the ʼ796 Patent”), which relates to a “deformable mechanical pipe coupling.” Independent claims 1, 21, 41 and 44 of the ʼ796 Patent each includes a “being deformable” limitation, which recites “said segments being deformable upon adjustable tightening of said connection members so as to substantially conform the curvature of said arcuate surfaces to the outer surfaces of said pipe elements within said circumferential grooves.”
In 2012, ASC requested inter partes reexamination of certain claims of the ʼ796 Patent, including claims 1, 21, 41 and 44. ASC’s request asserted obviousness grounds against those claims based on “Reynolds” and “Reynolds in view of Webb.” The USPTO instituted reexamination on both of those grounds but determined that the claims were “valid and patentable” in a final decision.
Notably, during reexamination, the USPTO agreed to add language to the “being deformable” limitation in claims 21, 41 and 44—but not in claim 1. However, the USPTO “mistakenly omitted” the added language from its decision, and the claims were not formally amended to add that language.
In 2020, Victaulic asserted claim 1 of the ʼ796 Patent against ASC in the District of Delaware, among other claims. In its invalidity contentions for claim 1, ASC again asserted “Reynolds” and “Reynolds in view of Webb.”
In a motion for summary judgment, Victaulic argued that ASC was estopped from asserting “Reynolds” or “Reynolds in view of Webb” against claim 1 under 35 U.S.C. § 315(c) because ASC raised those grounds in the reexamination proceedings. Section 315(c) states that a “third-party requester” like ASC is “estopped from asserting at a later time, in any civil action . . . the invalidity of any claim finally determined to be valid and patentable on any ground which the [] requester raised or could have raised during the inter partes reexamination proceedings.”
In response, ASC argued that its Reynolds and Webb-based obviousness grounds were not “raised” and “could not have been raised” in the reexamination proceedings because the two proceedings involve different claim interpretations of the “being deformable” limitation in claim 1. Specifically, ASC argued that, during reexamination, the USPTO applied a narrow interpretation of “being deformable” in claim 1 that necessarily included the additional language that was supposed to be added to claims 21, 41 and 41. Thus, according to ASC, estoppel should not apply because “Victaulic now asserts an interpretation of the [‘being deformable’] claim limitation . . . in claim 1 that is broader than the Board’s interpretation of the claim,” which presents new “issues” when asserting Reynolds and Webb in district court.
The District Court rejected ASC’s argument, ruled that estoppel applied, and granted summary judgment in favor of Victaulic. In coming to its conclusion, the District Court determined that “raised or could have raised” in § 315(c) refers to whether the same claims are at issue, not the same interpretations, citing In re Affinity Labs of Texas, LLC, 856 F.3d 883, 891-92 (Fed. Cir. 2017). When ASC requested reexamination, claim 1 “had the same language as it has now,” which “has only ‘one correct construction.’” Accordingly, even if Victaulic is applying a different construction than the USPTO, that “does not change either how the Court must construe that term or whether a party previously asserted that a claim which includes that term was obvious in an inter partes reexamination.” Accordingly, ASC was “estopped from asserting in this action that Claim 1 of the ʼ796 Patent is invalid as obvious in view of Webb and Reynolds because ASC raised or could have raised those invalidity grounds in the [reexamination].”
The District Court further noted in a footnote that “ASC could have raised its real argument—i.e., that the IPR added limitations to Claim 1” had it not “forfeited the chance to bring such a motion” (citing a sealed document).
Practice Tip: In light of estoppel provisions under pre- and post-AIA patent statutes, practitioners should proceed with caution when asserting the same prior art in district court that they asserted in prior proceedings, including reexaminations, before the USPTO. As shown in Victaulic, the Patent Act’s estoppel provisions are “severe” and may apply even if claims are interpreted or construed differently between the proceedings.
Victaulic Company v. ASC Engineered Sols., LLC., Civil Action No. 20-887-GBW (D. Del. Nov. 30, 2022).
Previous Entries
IP Newsflash
October 1, 2025
In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.
IP Newsflash
September 30, 2025
The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.
IP Newsflash
September 25, 2025
In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.
IP Newsflash
September 24, 2025
The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.
IP Newsflash
September 17, 2025
A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.
IP Newsflash
September 9, 2025
The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.
IP Newsflash
August 29, 2025
In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue.
IP Newsflash
August 29, 2025
The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).
© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.